DFN15 Versus Placebo in Patients With Migraine Headaches

Trial Profile

DFN15 Versus Placebo in Patients With Migraine Headaches

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Jun 2017

At a glance

  • Drugs DFN 15 (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Sponsors Dr Reddys Laboratories
  • Most Recent Events

    • 11 Jun 2017 Results of post hoc analysis evaluating variability of migraine symptoms (n=60), presented at the 59th Annual Scientific Meeting of the American Headache Society.
    • 11 Jun 2017 Results (n=60) presented at the 59th Annual Scientific Meeting of the American Headache Society.
    • 07 Jul 2016 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top